Comment on “Cost-effectiveness of rivaroxaban for stroke prevention in atrial fibrillation in the Portuguese setting” Luís Silva Miguel

Cost-effectiveness of rivaroxaban for stroke prevention in atrial fibrillation in the Portuguese setting João Morais, Carlos Aguiar, Euan McLeod, Ismini Chatzitheofilou, Isabel Fonseca Santos, Sónia Pereira

Comment on “Stroke Prevention in Atrial Fibrillation: A Systematic Review” Evangelista Rocha